ORGASM IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER

被引:0
|
作者
Mazzola, C. [1 ]
Teloken, P. E. [1 ]
Matsuhsita, K. [1 ]
Nelson, C. J. [1 ]
Mulhall, J. P. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源
JOURNAL OF SEXUAL MEDICINE | 2016年 / 13卷 / 05期
关键词
D O I
10.1016/j.jsxm.2016.02.111
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
104
引用
收藏
页码:S50 / S50
页数:1
相关论文
共 50 条
  • [1] ORGASM PROFILES IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Teloken, Patrick
    Mazzola, Clarisse R.
    Mulhall, John P.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E572 - E572
  • [2] Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer
    Breunis, H.
    Leach, M.
    Naglie, G.
    Tannock, I. F.
    Fleshner, N. E.
    Krahn, M.
    Duff-Canning, S.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] IMPACT OF ANDROGEN DEPRIVATION THERAPY (ADT) ON FATIGUE AMONG MEN WITH PROSTATE CANCER
    Cessna, Julie
    Lee, Morgan
    Donovan, Kristine
    Jim, Heather
    Jacobsen, Paul
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S270 - S270
  • [4] Androgen deprivation therapy (ADT) for node postive prostate cancer
    Wong, Y.
    Freedland, S.
    Hudes, G.
    Mitra, N.
    Montagnet, C.
    Armstrong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] MUSCULOSKELETAL HEALTH IN ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Zigoura, E.
    Veronese, N.
    Floris, A.
    Schiavone, C.
    Campodonico, F.
    Ennas, M.
    Pilotto, A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S282 - S282
  • [6] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen, Patrick J.
    Daly, Robin M.
    Dalla Via, Jack
    Mundell, Niamh L.
    Livingston, Patricia M.
    Rantalainen, Timo
    Fraser, Steve F.
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (04) : 403 - 411
  • [7] Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)
    Saad, F.
    Smith, M. R.
    Egerdie, B.
    Tammela, T. L.
    Feldman, R. A.
    Heracek, J.
    Szwedowski, M.
    Ke, C.
    Leder, B.
    Goessl, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
    Mohamad, Nur-Vaizura
    Soelaiman, Ima-Nirwana
    Chin, Kok-Yong
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2017, 17 (04) : 276 - 284
  • [9] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Patrick J. Owen
    Robin M. Daly
    Jack Dalla Via
    Niamh L. Mundell
    Patricia M. Livingston
    Timo Rantalainen
    Steve F. Fraser
    Calcified Tissue International, 2019, 105 : 403 - 411
  • [10] The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
    Lawrenson, Ross
    Obertova, Zuzana
    Brown, Charis
    Fong, Peter
    Tyrie, Leanne
    Scott, Nina
    Holmes, Michael
    JOURNAL OF CANCER, 2014, 5 (03): : 214 - 220